In bone marrow transplantation models using TRAIL-deficient mice, TRAIL is essential for optimal graft-versus-tumor activity by donor T cells, while it plays little or no role in the development of graft-versus-host disease [6,7]. The gene discussed is TNFSF10; the disease is neoplasm.